Skip Navigation
Search Menu
Gynecology & Obstetrics

In This Section      

Center for Rare Gynecologic Cancers

Dr. Fader talking to a patient in a hospital bed

Our institution is home to one of the only programs dedicated to treating women with uncommon malignancies — the Center for Rare Gynecologic Cancers. Our center emphasizes personalized care for women with uterine sarcomas, low-grade serous ovarian carcinoma, uterine serous carcinoma, clear cell and mucinous tumors of the ovary, germ cell and sex cord stromal tumors of the ovary, vulvar melanoma, neuroendocrine carcinoma of the cervix and gestational trophoblastic tumors.

The complexity of these cancers necessitates a treatment team with superior investigative, surgical and analytical skills. Amanda Fader, M.D., is a national leader in rare gynecologic cancer research and has focused much of her work on treating women with these rare cancers and offering them innovative, individualized and targeted therapies.

As a member of the rare tumor group of the National Cancer Institute's NRG Oncology, Dr. Fader and her colleagues offer the most state-of-the-art clinical trials for women with uncommon malignancies.

Where you decide to go for care has a major effect on your outcome. Choose the team with the track record and determination to combat the rarest gynecologic cancers.